Halozyme(HALO) - 2025 Q2 - Earnings Call Transcript

Halozyme Therapeutics (HALO) Q2 2025 Earnings Call August 05, 2025 04:30 PM ET Company ParticipantsTram Bui - Vice President, Investor Relations and Corporate CommunicationsHelen Torley - President, CEO & DirectorNicole LaBrosse - Chief Financial OfficerCerena Chen - VP - Biotech and Pharma Equity ResearchSean Laaman - Executive DirectorJason Butler - MD & Biotechnology Equity ResearchAdam Ferrari - Biotech Equity Research AssociateMichael Difiore - Managing DirectorCorinne Johnson - Vice PresidentConferenc ...